Scoliosis Clinical Trials

Find Scoliosis Clinical Trials Near You

PURICA : Purine Supplementation in Patients With AICA-Ribosiduria

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

AICA-Ribosiduria due to ATIC deficiency is a rare genetic metabolic disease that affects less than 10 patients (PMID: 32557644). It results in severe polyhandicap linked to neurodevelopmental disorders, visual impairment, growth retardation, severe spinal deformities and scoliosis, and often early-onset epilepsy. The disease is caused by dysfunction of the ATIC enzyme, which is involved in de novo purine biosynthesis. A recent study (PMID: 38244287) reported a decrease in disease biomarkers in a single patient after 3 months on a purine-rich diet, which persisted for at least 1 year. The investigators propose to replicate this study on several patients to investigate the potential of this treatment for this severe orphan disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Healthy Volunteers: f
View:

• Individual affected by AICA-ribosiduria due to ATIC deficiency

Locations
Other Locations
France
Chu Saint-Etienne
RECRUITING
Saint-etienne
Contact Information
Primary
Francis RAMOND, doctor of medicine
Francis.Ramond@chu-st-etienne.fr
0477828798
Backup
Béatrice DEYGAS, Project manager
beatrice.deygas@chu-st-etienne.fr
Time Frame
Start Date: 2025-04-24
Estimated Completion Date: 2029-05
Participants
Target number of participants: 10
Treatments
Experimental: Individual with AICA-ribosiduria due to ATIC deficiency
Individual with AICA-ribosiduria due to ATIC deficiency
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Saint Etienne
Collaborators: University Hospital of Saint-Etienne

This content was sourced from clinicaltrials.gov